| News
Early mover: NextDay.Vision is first tenant at Switzerland Innovation Park Basel Area in Jura
26.09.2019
One month before the official opening, the Jura site of the Switzerland Innovation Park Basel Area welcomes its first tenant: NextDay.Vision, a start-up from the Jura, opens its office at the park. The company was also one of the winners of the i4Challenge 2018.
Philippe Kapfer, CEO NextDay.Vision
Being in the Jura comes with advantages for the company: Customers and partners in Basel, Bern, Neuchâtel, Geneva and Paris are easily accessible by train. Being close to the many SMEs in the Jura further provides the possibility to easily deploy and improve new products, adapting them to the needs of the customers. To CEO Philippe Kapfer, the Jura site of the innovation park is the perfect place to innovate, to share and to grow. “We are convinced that the Switzerland Innovation Park Basel Area will help us in creating new partnerships and in finding new customers.” He appreciates the effort that the canton makes to attract and to keep innovative companies. “We are one of these innovators. There is no reason for us to go elsewhere,” Kapfer says.
CEO Philippe Kapfer is a cybersecurity specialist and author of a book on Internal Hacking. He founded his start-up to develop software solutions in computer security in 2017. NextDay.Vision also offers IT security consulting as well as conferences and trainings on security awareness. NextDay.Vision recently released its first product: OtpOne API replaces passwords in company business applications. “Our next plans are to develop some tools related to our technology to provide IT companies with more comfort and security. Further, we want to develop cybersecurity audits and raise awareness in order to protect local SMB companies from hackers.” NextDay.Vision also collaborates with a reseller in Canada to open new markets.
The CEO hopes for a thriving community at the innovation park and looks forward to finding complementary profiles of entrepreneurs and skills in order to work together and to create something new. Philippe Kapfer also enjoys the other qualities of the Jura: “The region is just beautiful.”
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
Moderna driving forward production of vaccine from Basel
Moderna is opening a location in Basel and is advancing the production of the coronavirus vaccine from there. The Swiss government has just signed a supply contract with the US company for 4.5 million doses of the vaccine.
Read More
Yokogawa establishes innovation center in Allschwil
The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.
Read More
Basel gains new biotech in Bright Peak
Versant Ventures has made a US$35 million Series A funding commitment to Bright Peak Therapeutics and has now announced the debut of this biotech. It will operate in Basel and San Diego.
Read More
Robots from Basel set to revolutionize surgery
The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.
Read More
T3 Pharma raises over 25 million Swiss francs
T3 Pharmaceuticals AG has closed its third financing round, raising over 25 million Swiss francs. The Basel-based startup has developed a bacterial cancer therapy that it now intends to progress to clinical trials.
Read More
Versameb raises 6 million Swiss francs
The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.
Read More
Genedata accelerating drug development
Genedata, a Basel IT company specializing in the life sciences sector, has agreed a collaboration with Thermo Fisher. The integration of their two platforms will help accelerate the development of drugs.
Read More
Basel is “probably the most productive life sciences location in the world”
Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.
Read More
Basel Area cantons publish joint economic report
The cantons of Basel-Landschaft, Basel-Stadt and Jura have just published their first joint Economic Report. The fundamental environment is described as “good” in the report.
Read More
Resistell receives high-level EU grant
Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.
Read More
